🇺🇸 FDA
Patent

US 7446124

Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

granted A61KA61K31/337A61K31/35

Quick answer

US patent 7446124 (Wortmannin analogs and methods of using same in combination with chemotherapeutic agents) held by Arizona Board of Regents, Acting on Behalf of the University of Arizona expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents, Acting on Behalf of the University of Arizona
Grant date
Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/337, A61K31/35, A61K31/366, A61K31/40